Your browser doesn't support javascript.
loading
Monthly oral ibandronate is effective and well tolerated after 3 years: the MOBILE long-term extension.
Stakkestad, Jacob A; Lakatos, Peter; Lorenc, Roman; Sedarati, Farhad; Neate, Colin; Reginster, Jean-Yves.
Affiliation
  • Stakkestad JA; CECOR AS, Nygårdsvegen 6, P.O. Box 1364 Gard, 5507, Haugesund, Norway. jas@cecor.no
Clin Rheumatol ; 27(8): 955-60, 2008 Aug.
Article in En | MEDLINE | ID: mdl-18180976
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Diphosphonates / Bone Density Conservation Agents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: Clin Rheumatol Year: 2008 Document type: Article Affiliation country: Noruega Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Diphosphonates / Bone Density Conservation Agents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: Clin Rheumatol Year: 2008 Document type: Article Affiliation country: Noruega Country of publication: Alemania